跳到內容

重症加護中心

抗凝血之處置和抗凝逆轉

Reversal of antithrombotic agents. (開啟新視窗)

Bauer KA.

出處‎: Am J Hematol 2012;87 Suppl 1:S119-26.

檢索‎: PubMed 22460529

DOI碼‎: 10.1002/ajh.23165

https://www.ncbi.nlm.nih.gov/pubmed/22460529 (開啟新視窗)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (開啟新視窗)

Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M

出處‎: J Thromb Haemost 2015;13(10):1790-8.

檢索‎: PubMed 26270886

DOI碼‎: 10.1111/jth.13117

https://www.ncbi.nlm.nih.gov/pubmed/26270886 (開啟新視窗)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (開啟新視窗)

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators

出處‎: N Engl J Med 2019;380(14):1326-35.

檢索‎: PubMed 30730782

DOI碼‎: 10.1056/NEJMoa1814051

https://www.ncbi.nlm.nih.gov/pubmed/30730782 (開啟新視窗)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (開啟新視窗)

Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators

出處‎: N Engl J Med 2016;375(12):1131-41.

檢索‎: PubMed 27573206

DOI碼‎: 10.1056/NEJMoa1607887

https://www.ncbi.nlm.nih.gov/pubmed/27573206 (開啟新視窗)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (開啟新視窗)

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M

出處‎: Circulation 2011;124(14):1573-9.

檢索‎: PubMed 21900088

DOI碼‎: 10.1161/CIRCULATIONAHA.111.029017

https://www.ncbi.nlm.nih.gov/pubmed/21900088 (開啟新視窗)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (開啟新視窗)

Gordon JL, Fabian TC, Lee MD, Dugdale M

出處‎: J Trauma Acute Care Surg 2013;75(3):475-86.

檢索‎: PubMed 24089118

DOI碼‎: 10.1097/TA.0b013e3182a07391

https://www.ncbi.nlm.nih.gov/pubmed/24089118 (開啟新視窗)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (開啟新視窗)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

出處‎: Am J Hematol 2012;87 Suppl 1:S141-5.

檢索‎: PubMed 22473649

DOI碼‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (開啟新視窗)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (開啟新視窗)

Levi M, Eerenberg E, Kamphuisen PW.

出處‎: J Thromb Haemost 2011;9(9):1705-12.

檢索‎: PubMed 21729240

DOI碼‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (開啟新視窗)

Emergency reversal of warfarin anticoagulation. (開啟新視窗)

Lin Y, Callum J.

出處‎: CMAJ 2010;182(18):2004.

檢索‎: PubMed 21078740

DOI碼‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (開啟新視窗)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (開啟新視窗)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

出處‎: Thromb Haemost 2012;108(2):217-24.

檢索‎: PubMed 22627883

DOI碼‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (開啟新視窗)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (開啟新視窗)

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group.

出處‎: J Thromb Haemost 2008;6(4):622-31.

檢索‎: PubMed 18208533

DOI碼‎: 10.1111/j.1538-7836.2008.02904.x

https://www.ncbi.nlm.nih.gov/pubmed/18208533 (開啟新視窗)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (開啟新視窗)

Piran S, Khatib R, Schulman S, Majeed A, Holbrook A, Witt DM, Wiercioch W, Schünemann HJ, Nieuwlaat R

出處‎: Blood Adv 2019;3(2):158-67.

檢索‎: PubMed 30658963

DOI碼‎: 10.1182/bloodadvances.2018024133

https://www.ncbi.nlm.nih.gov/pubmed/30658963 (開啟新視窗)

Idarucizumab for dabigatran reversal. (開啟新視窗)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

出處‎: N Engl J Med 2015;373(6):511-20.

檢索‎: PubMed 26095746

DOI碼‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (開啟新視窗)

Idarucizumab for dabigatran reversal - full cohort analysis. (開啟新視窗)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

出處‎: N Engl J Med 2017;377(5):431-41.

檢索‎: PubMed 28693366

DOI碼‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (開啟新視窗)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (開啟新視窗)

Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B

出處‎: Blood 2003;102(13):4594-9.

檢索‎: PubMed 12920042

DOI碼‎: 10.1182/blood-2002-11-3566

https://www.ncbi.nlm.nih.gov/pubmed/12920042 (開啟新視窗)

Role of agents for reversing the effects of target-specific oral anticoagulants. (開啟新視窗)

Riley TR, Gauthier-Lewis ML, Sanchez CK, Douglas JS

出處‎: Am J Health Syst Pharm 2017;74(2):54-61.

檢索‎: PubMed 27895055

DOI碼‎: 10.2146/ajhp150810

https://www.ncbi.nlm.nih.gov/pubmed/27895055 (開啟新視窗)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (開啟新視窗)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

出處‎: Anesth Analg 2011;113(4):703-10.

檢索‎: PubMed 21890888

DOI碼‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (開啟新視窗)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (開啟新視窗)

Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS

出處‎: J Am Coll Cardiol 2017;70(24):3042-67.

檢索‎: PubMed 29203195

DOI碼‎: 10.1016/j.jacc.2017.09.1085

https://www.ncbi.nlm.nih.gov/pubmed/29203195 (開啟新視窗)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (開啟新視窗)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

出處‎: World Neurosurg 2014;81(1):110-5.

檢索‎: PubMed 23220122

DOI碼‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (開啟新視窗)

Reversal of warfarin-induced hemorrhage in the emergency department. (開啟新視窗)

Zareh M, Davis A, Henderson S.

出處‎: West J Emerg Med 2011;12(4):386-92.

檢索‎: PubMed 22224125

DOI碼‎: 10.5811/westjem.2011.3.2051

https://www.ncbi.nlm.nih.gov/pubmed/22224125 (開啟新視窗)